NYSE:MDT
NYSE:MDTMedical Equipment

Medtronic (NYSE:MDT) Secures FDA Approval For Innovative OmniaSecure Defibrillation Lead

Medtronic (NYSE:MDT) recently announced FDA approval of its OmniaSecure™ defibrillation lead, marking a key advancement in cardiovascular technology, along with results from its LEADR LBBAP study showing a 100% defibrillation success rate. Over the past week, Medtronic's stock price increased by 1.9%, a move that aligned with these positive developments but was modest compared to the broader market's 4.7% rise. While Medtronic's innovative product developments could have added weight to its...
NasdaqGS:AMGN
NasdaqGS:AMGNBiotechs

Amgen (NasdaqGS:AMGN) Expands Ohio Facility With US$900 Million Investment

Amgen (NasdaqGS:AMGN) recently announced a significant $900 million expansion in its Ohio manufacturing facility, aiming to strengthen its biomanufacturing capabilities. This investment is part of a strategic focus on enhancing U.S. manufacturing, alongside its $1 billion commitment to a new plant in North Carolina. Over the past quarter, Amgen's stock price moved by 2%, while the broader market increased by 8%. Although the company's investment plans signal long-term growth, this moderate...
NasdaqGS:CHTR
NasdaqGS:CHTRMedia

Charter Communications (NasdaqGS:CHTR) Reports Q1 Earnings Growth and New Director Appointment

Charter Communications (NasdaqGS:CHTR) recently experienced a 10% share price increase over the past week. This move coincides with the company's release of strong first-quarter earnings results, reporting a rise in both net income and earnings per share. Additionally, the election of Martin E. Patterson to the board during its Annual Meeting of Stockholders underscores changes in leadership. Despite these impactful developments, the market itself also saw growth of nearly 5% during this...